| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-05 |
| mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-05 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-05 |
| mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |